Improving Treatments and Outcomes with Cardiovascular Imaging


Track the evolution of cardiovascular imaging agents over the past 40 years and get a preview of what’s to come. Presenters will examine the decision-making process for selecting the optimal SPECT and PET agents for each patient’s treatment plan. They’ll also discuss alternative cardiovascular imaging modalities and how these options expand the cardiologist’s toolbox for treatment planning options.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Explain how the various mechanisms of localization of the various cardiovascular imaging radiopharmaceuticals support different indications.
  2. Explain the clinical utility of different pharmacologic stress agents.
  3. Discuss the application of various cardiovascular imaging options and their impact on treatment planning and outcome.

Joint Providership

This activity is approved for Board Certified Nuclear Pharmacist (BCNP) recertification credits.

mark soffing, MBA, MS, PharmD
Associate Director
Kreitchman PET Center, Columbia University Medical Center
Jamieson Bourque, MD, MHS
Associate Professor of Medicine and Radiology
University of Virginia
Monvadi Srichai-Parsia,
Associate Professor
Medstar Georgetown University Hospital
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Sunday, March 22
1:00 PM - 4:00 PM
Gaylord National Resort - Chesapeake A-C
ACPE Pharmacist: 0202-0000-20-040-L04-P
CEUs Pharmacist: 0.3
Activity Type: